This is dangerous. Not only will this be rife with insider trading with no regulation. It could really undermine the scientific process and equipoise. Who would want to enroll in a trial that the market is betting against (for good or bad reasons)? @PavlosMsaouel@ebludmir
Been exploring practical ways to integrate publicly available LLMs into my workflow. With just a clear, well-crafted prompt, I set up a "manuscript reader assistant" to help me review papers and bounce ideas with ChatGPT. Prompt below 👇
https://t.co/GC3MVsMNos
Paging all Internal Medicine Residency applicants, join us in our Open House on 09/16 to learn about our program and chat with the Chiefs. Registration link https://t.co/KR1EA4FncQ
Thank you @ASE360 for selecting me as one of the Top Investigators at the #ASE2023. Truly an honor!
Also did I even attend a conference if I did not tweet about it? @IUIntMed
Another successful conference in the books! Catching up with friends/mentors and presenting our research on the role of coronary reactivity testing in reducing costs for patients with #ANOCA in addition to posters regarding #PFE and #NBTE. #ACC23#WCCardio#CardioTwitter
Before lockdown I had been working on a demo of a new version of ‘Comfortably Numb’ as an opener to our new show "This Is Not A Drill”. I pitched it a whole step down, in A Minor, to make it darker and arranged it with no solos...
Read more: https://t.co/m8IlU931Dn
Proud to share the primary results of our randomized trial comparing suture mediated closure to manual compression/figure-of-eight in AF ablation. Thanks to everyone for their support on this team effort!
https://t.co/zA9ompRZVc
#EPeeps@SanjayaKGupta1
Excited to share our work. Curious to hear what others do in the face of more and more data with (perhaps) less clinical context? Thanks to our outstanding colleagues on this! @FaisalMMerchant@melchami99@danealson @MAlGibbawi @AnandShah_MD#EPeeps